H.R.1, One Big Beautiful Bill Act of 2025, provisions relating to Section 899 of US Tax Code. Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics.
Literal federal measure citations: H.R.1
2025 · 2nd Quarter (Apr 1 - June 30)
BIOMERIEUX, INC.
Filed by ALSTON & BIRD LLP.
Open official filingSource-reported fields
Filing overview
- Type
- 2nd Quarter - Report
- Posted
- Jul 21, 2025
- Income
- $30,000.00
- Expenses
- Not reported
- Registrant
- ALSTON & BIRD LLP
- Client
- BIOMERIEUX, INC.
- Filing UUID
- 2a471cbf-f2f1-40c8-ac24-b0c95c4a192f
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment (per Section 216 of Protecting Access to Medicare Act (PAMA)).
Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment (per Section 216 of Protecting Access to Medicare Act (PAMA)).
Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment (per Section 216 of Protecting Access to Medicare Act (PAMA)).
Discussions regarding tariff proposals.
H.R.1, One Big Beautiful Bill Act of 2025, provisions relating to Section 899 of US Tax Code.
Literal federal measure citations: H.R.1
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.